{"id":"https://openalex.org/W1991976737","doi":"https://doi.org/10.1046/j.1365-2141.1999.01598.x","title":"Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia","display_name":"Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia","publication_year":1999,"publication_date":"1999-09-01","ids":{"openalex":"https://openalex.org/W1991976737","doi":"https://doi.org/10.1046/j.1365-2141.1999.01598.x","mag":"1991976737","pmid":"https://pubmed.ncbi.nlm.nih.gov/10468856"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2141.1999.01598.x","doi":"https://doi.org/10.1046/j.1365-2141.1999.01598.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.1999.01598.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070182290","display_name":"Soo\u2010Young Yoon","orcid":"https://orcid.org/0000-0002-2302-3825","observed_orcids":["https://orcid.org/0000-0002-2302-3825"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I197347611","display_name":"Korea University","ror":"https://ror.org/047dqcg40","country_code":"KR","type":"education","lineage":["https://openalex.org/I197347611"]}],"countries":["KR","US"],"is_corresponding":false,"raw_author_name":"Soo\u2010Young Yoon","raw_affiliation_strings":["Division of Hematopathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA",", Korea University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematopathology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":", Korea University","institution_ids":["https://openalex.org/I197347611"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111801384","display_name":"Chin\u2010Yang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chin\u2010Yang Li","raw_affiliation_strings":["Division of Hematopathology,","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematopathology,","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039057642","display_name":"Ruben A. Mesa","orcid":"https://orcid.org/0000-0001-5880-7972","observed_orcids":["https://orcid.org/0000-0001-5880-7972"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ruben A. Mesa","raw_affiliation_strings":["Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, U.S.A","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, U.S.A","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016216479","display_name":"Ayalew Tefferi","orcid":"https://orcid.org/0000-0003-4605-3821","observed_orcids":["https://orcid.org/0000-0003-4605-3821"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ayalew Tefferi","raw_affiliation_strings":["Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, U.S.A","Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, U.S.A","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111801384"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":1.9727,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.85307517,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"106","issue":"3","first_page":"682","last_page":"688"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anagrelide","display_name":"anagrelide","score":0.996999979019165},{"id":"https://openalex.org/keywords/myelofibrosis-with-myeloid-metaplasia","display_name":"myelofibrosis with myeloid metaplasia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/bone-marrow","display_name":"bone marrow","score":0.7129999995231628},{"id":"https://openalex.org/keywords/megakaryocytes","display_name":"megakaryocytes","score":0.9070000052452087},{"id":"https://openalex.org/keywords/megakaryocyte-maturation","display_name":"megakaryocyte maturation","score":0.9980000257492065},{"id":"https://openalex.org/keywords/megakaryocyte-proliferation","display_name":"megakaryocyte proliferation","score":0.781000018119812},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.781000018119812},{"id":"https://openalex.org/keywords/platelet-derived-growth-factor","display_name":"platelet-derived growth factor","score":0.9860000014305115},{"id":"https://openalex.org/keywords/bone-marrow-fibrosis","display_name":"bone marrow fibrosis","score":0.8529999852180481},{"id":"https://openalex.org/keywords/osteosclerosis","display_name":"osteosclerosis","score":0.968999981880188},{"id":"https://openalex.org/keywords/platelet-responsiveness","display_name":"platelet response","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ulex-europaeus-agglutinin-1","display_name":"UEA-1","score":0.949999988079071}],"concepts":[{"id":"https://openalex.org/C2780829020","wikidata":"https://www.wikidata.org/wiki/Q408163","display_name":"Anagrelide","level":4,"score":0.9808897972106934},{"id":"https://openalex.org/C2779705218","wikidata":"https://www.wikidata.org/wiki/Q821701","display_name":"Megakaryocyte","level":4,"score":0.8671544790267944},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.843018651008606},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.7914977073669434},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.6105373501777649},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.5612824559211731},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.48062199354171753},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4761117398738861},{"id":"https://openalex.org/C2779788118","wikidata":"https://www.wikidata.org/wiki/Q1542410","display_name":"Thrombocytosis","level":3,"score":0.4637710452079773},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44751664996147156},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.3281412124633789},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.2997698187828064},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.2315674126148224},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.10187828540802002},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06277525424957275},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010976","descriptor_name":"Platelet Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1365-2141.1999.01598.x","doi":"https://doi.org/10.1046/j.1365-2141.1999.01598.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2141.1999.01598.x","pdf_url":null,"source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:10468856","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10468856","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W118940326","https://openalex.org/W303701243","https://openalex.org/W339601887","https://openalex.org/W1209159546","https://openalex.org/W1494589518","https://openalex.org/W1927178045","https://openalex.org/W1966507279","https://openalex.org/W1973631902","https://openalex.org/W1990296696","https://openalex.org/W1993701574","https://openalex.org/W2003597939","https://openalex.org/W2008647897","https://openalex.org/W2029318538","https://openalex.org/W2038023702","https://openalex.org/W2056740371","https://openalex.org/W2080664913","https://openalex.org/W2094855567","https://openalex.org/W2150656708","https://openalex.org/W2321503226","https://openalex.org/W2411289820","https://openalex.org/W2416924654","https://openalex.org/W2417072257","https://openalex.org/W3114368461","https://openalex.org/W4321746732","https://openalex.org/W6650105057"],"related_works":["https://openalex.org/W2137496208","https://openalex.org/W39517730","https://openalex.org/W7026662244","https://openalex.org/W7063994145","https://openalex.org/W2003597939","https://openalex.org/W213852629","https://openalex.org/W118940326","https://openalex.org/W2030435811","https://openalex.org/W2026373389","https://openalex.org/W7046865489"],"abstract_inverted_index":{"In":[0,72],"a":[1,34,45,94,102,128,157],"prospective":[2],"study":[3],"investigating":[4],"the":[5,164],"therapeutic":[6],"role":[7],"of":[8,23,36,61,83,91,156,174],"anagrelide":[9,18,32,84,147,167],"in":[10,19,98,132],"myelofibrosis":[11],"with":[12,101,149,163],"myeloid":[13],"metaplasia,":[14],"20":[15],"patients":[16,27,100],"received":[17,31],"daily":[20],"oral":[21],"doses":[22],"0.5-3":[24],"mg.":[25],"17":[26,67],"were":[28,63],"evaluable":[29,74],"and":[30,55,58,68,114,176],"for":[33,65,111],"median":[35],"2":[37],"years":[38],"(range":[39],"0.5-4":[40],"years).":[41],"No":[42,125],"patient":[43,126],"had":[44,127],"clinically":[46],"appreciable":[47],"benefit.":[48],"Bone":[49],"marrow":[50],"(BM)":[51],"examinations":[52],"at":[53],"baseline":[54],"after":[56,80],"6":[57,81],"12":[59,69],"months":[60,82],"treatment":[62,159],"available":[64],"17,":[66],"patients,":[70],"respectively.":[71],"all":[73],"cases,":[75],"BM":[76,134],"megakaryocyte":[77,108,150,172],"number":[78],"increased":[79],"treatment.":[85,124],"Also,":[86],"Ulex":[87],"europaeus":[88],"agglutinin-1":[89],"staining":[90,109],"megakaryocytes":[92],"revealed":[93],"left-shifted":[95],"maturation":[96,151],"pattern":[97],"most":[99],"platelet":[103],"response":[104],"to":[105],"anagrelide.":[106],"However,":[107],"intensity":[110],"transforming":[112],"(TGF-beta)":[113],"platelet-derived":[115],"(PDGF)":[116],"growth":[117],"factors":[118],"was":[119],"not":[120,169],"affected":[121],"consistently":[122],"by":[123],">/=2":[129],"grade":[130],"change":[131],"either":[133],"fibrosis":[135],"or":[136],"osteosclerosis.":[137],"These":[138],"in-vivo":[139],"data":[140],"support":[141],"our":[142],"previous":[143],"in-vitro":[144],"observations":[145],"that":[146,166],"interferes":[148],"rather":[152],"than":[153],"proliferation.":[154],"Lack":[155],"positive":[158],"effect":[160],"is":[161],"consistent":[162],"finding":[165],"did":[168],"significantly":[170],"alter":[171],"expression":[173],"TGF-beta":[175],"PDGF.":[177]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}